On this page
How should the drug substance container-closure system be described in CTD S.6?
Identify the actual packaging components, contact materials and applicable controls, then explain suitability for storing and distributing the substance. Connect the proposed configuration to manufacturing instructions and stability evidence. Separate the identity of a container from evidence that it protects and is compatible with the substance.
Before you begin
M4Q(R1) S.6 for substance containers; finished-product packaging belongs in P.7.
What you will prepare: A defined container system whose components, controls and suitability match the proposed storage and transport context.
Describe the complete system and its scope
Gather approved packaging drawings, component specifications, supplier material records and the S.2 filling/storage description. Identify each primary component and material of construction, relevant dimensions and drawings, and the specifications controlling it. Include applicable noncompendial methods and their validation information. Distinguish a contact liner from an outer shipping drum; the outer label alone does not identify the contact material.
Describe nonfunctional secondary packaging briefly. Where secondary packaging provides protection or another function, give the information needed to understand that function. If multiple systems are proposed, name them consistently and identify the substance/process instances to which each applies.
Connect suitability to the proposed use
Explain protection from relevant external factors, material compatibility and safety using actual evidence. Consider sorption or leaching where scientifically relevant rather than claiming all packaging is inert. Link the storage proposal to the S.7 stability container and the manufacturing/storage/transport description in S.2.
A component specification is evidence of what is controlled, not by itself evidence that the system protects this substance. Ask packaging and stability owners to resolve an untested configuration, supplier change or missing material identity. Record any supported rationale for bridging; do not assume two components are equivalent because both are described as plastic.
Worked review: the liner changed
Fictional exercise: stability batches used liner A, while the proposed supply specification names liner B. Both fit the same drum. The author cannot establish whether the materials are equivalent.
Keep the systems separately identified and obtain a scientific assessment of the change and the evidence supporting the proposed shelf life or retest period. Review S.7's conclusion and S.2's storage instructions after resolution. Do not update the stability table to say “commercial container” unless the underlying study actually used the proposed system or a justified relationship is transparently described.
Match component identity to the studied configuration
Use a packaging cross-check that distinguishes the controlled component from its function. The table below is a preparation aid, not a universal testing specification.
| Item | Record to compare | Consequence of a mismatch |
|---|---|---|
| Primary contact component | Material identity, drawing and supplier specification | A liner change can alter the substance-contact system |
| Protective component | Intended protection and supporting assessment | An outer component may matter despite no direct contact |
| Stored substance | Process/material instance and relevant properties | Evidence for one form may not support another |
| Stability configuration | Actual study package and proposed supply package | A generic “commercial pack” label may hide differences |
Fictional review: the packaging description lists a drum, but the study record identifies a double liner inside it. Add the actual configuration and determine which component provides the relevant protection or compatibility. Naming the outer drum does not describe everything the substance contacts.
For a change, record what differs and what evidence supports the relationship to the studied system. Dimensional compatibility is only one question; the packaging and stability experts should assess the relevant material and performance implications.
Reconcile S.7 stability and S.2 storage or transfer instructions. Where suitability remains unresolved, keep the package-specific proposal conditional rather than relabeling old study records.
Your preparation checklist
0/3 checkedUse this to track your review in this visit. Checks are not saved and do not establish regulatory compliance.
Frequently asked questions
Does a component specification prove packaging suitability?
No. It describes controlled characteristics of the component. Suitability concerns how the system performs with the actual substance under the proposed conditions. Connect the component description to the relevant protection, compatibility and safety evidence rather than treating the specification as the complete assessment.
Can a different liner be treated as the same container?
Do not assume equivalence from the shared outer drum or dimensions. Identify the liner material and change, then obtain the appropriate packaging and stability assessment. Describe the supported relationship transparently rather than changing the identity of the package used in a historical study.
Should secondary packaging always be omitted from S.6?
No. M4Q distinguishes nonfunctional secondary packaging from components with protective or other functions. A brief description can be appropriate for nonfunctional packaging, while functional components need enough information to understand their role in the proposed system.
Sources and revisions
Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.
Guidance
ICH M4Q(R1): CTD Quality ↗Step 4, September 12, 2002; Module 3, printed pages 5–18. Organization/content guidance, not a universal list of required studies. Checked September 22, 2026. Guide-specific passages: 3.2.S.6, printed pages 10–11.
Technical specification · placement only
FDA eCTD v4.0 comprehensive hierarchy ↗Version 2.2, February 2025. Section 3.2.S.6. A heading identifies placement, not mandatory applicability.